ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
96.63
+2.47 (2.62%)
Jun 26, 2026, 2:01 PM EDT - Market open

BIB Holdings Information

BIB is an equity ETF with a total of 261 individual holdings.

Total Holdings
261
Top 10 Percentage
158.60%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
69.83M
PE Ratio
n/a

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1n/aNASDAQ BIO INDEX SWAP BNP PARIBAS41.30%4,982
2n/aNASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA29.22%3,524
3n/aNASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA23.90%2,883
4n/aNASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL21.88%2,639
5n/aNASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE20.83%2,513
6n/aNASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG5.25%633
7VRTXVertex Pharmaceuticals Incorporated4.72%7,525
8AMGNAmgen Inc.4.64%9,997
9GILDGilead Sciences, Inc.4.14%25,047
10REGNRegeneron Pharmaceuticals, Inc.2.72%3,307
11ALNYAlnylam Pharmaceuticals, Inc.1.66%4,287
12RVMDRevolution Medicines, Inc.1.53%6,826
13BIIBBiogen Inc.1.25%4,741
14ILMNIllumina, Inc.1.12%4,861
15ROIVRoivant Sciences Ltd.1.04%23,098
16RPRXRoyalty Pharma plc1.02%14,243
17MRNAModerna, Inc.1.02%12,748
18ARGXargenx SE1.00%887
19UTHRUnited Therapeutics Corporation0.99%1,363
20INSMInsmed Incorporated0.95%6,963
21INCYIncyte Corporation0.92%6,417
22VTRSViatris Inc.0.79%37,401
23GHGuardant Health, Inc.0.77%4,259
24NBIXNeurocrine Biosciences, Inc.0.71%3,230
25ASNDAscendis Pharma A/S0.62%1,979
Showing 25 of 261 holdings
Subscribe to see the full list
As of Jun 24, 2026